Risk of Leukemia Following Treatment for Non-Hodgkin's Lymphoma

Background: There have been few evaluations of the risk of acute nonlymphocytic leukemia (ANLL) following therapy for non-Hodgkin's lymphoma (NHL). Further, the relationship between cumulative dose of cytotoxic drug, radiation dose to active bone marrow, and the risk of ANLL following NHL have...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JNCI : Journal of the National Cancer Institute 1994-10, Vol.86 (19), p.1450-1457
Hauptverfasser:	Travis, Lois B., Curtis, Rochelle E., Stovall, Marilyn, Holowaty, Eric J., van Leeuwen, Flora E., Glimelius, Bengt, Lynch, Charles F., Hagenbeek, Anton, Li, Chin-Yang, Banks, Peter M., Gospodarowicz, Mary K., Adami, Johanna, Wacholder, Sholom, Inskip, Peter D., Tucker, Margaret A., Boice, John D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Bone marrow Case-Control Studies Chemotherapy Dose-Response Relationship, Drug Dose-Response Relationship, Radiation Female Humans Leukemia Leukemia, Myeloid, Acute - chemically induced Leukemia, Myeloid, Acute - etiology Leukemia, Radiation-Induced - etiology Logistic Models Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - radiotherapy Lymphoma, Non-Hodgkin - therapy Male Medical research Middle Aged Neoplasms, Second Primary - chemically induced Radiation Radiotherapy - adverse effects Registries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!